Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury.
about
microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentPaving the Route to Plasma miR-208a-3p as an Acute Cardiac Injury Biomarker: Preclinical Rat Data Supports Its Use in Drug Safety Assessment.Creating a Biomarker Panel for Early Detection of Chemotherapy Related Cardiac Dysfunction in Breast Cancer PatientsOne-pot synthesis of cinnamylideneacetophenones and their in vitro cytotoxicity in breast cancer cellsEffect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study--A Single-Center, Blinded, Randomized Controlled Trial.Enzyme-assisted target recycling (EATR) for nucleic acid detection.Noncoding RNA response to xenobiotic exposure: an indicator of toxicity and carcinogenicity.Development and regulatory application of microRNA biomarkers.Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients.Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.In Silico Pharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined Classifiers.Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment.
P2860
Q26778918-86F6038B-76B5-4B3A-90E3-A9FE0CD9D7B2Q31004210-91AEC219-FBF4-49D1-A309-3A8BF0F44B44Q33816471-D57BF57D-274D-48AB-8E31-26410182124BQ34094228-526B1298-E6EF-4305-80E8-19EC0D9CF636Q36894836-EA52ED74-328C-445B-8993-A25C9B054104Q38217860-410A52CD-EE72-4A22-B0F6-E3EF3DE6FECCQ38244618-53DB07ED-7388-4718-9439-A1C7EAA03E90Q38616581-83A36FAB-7BBC-43E0-9B29-DD4D9B10C5A2Q49163835-59E0CC57-E725-410D-A29D-E4EACD5CBE63Q49315568-56EA6382-1D09-49E5-83A0-5AAC44CDCDD8Q55339567-84ADC7E0-3A37-47F9-9767-22ED20715397Q55429574-6CFCAE40-C4A7-4489-832C-66780B9CF320
P2860
Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular basis of cancer-ther ...... subclinical myocardial injury.
@en
type
label
Molecular basis of cancer-ther ...... subclinical myocardial injury.
@en
prefLabel
Molecular basis of cancer-ther ...... subclinical myocardial injury.
@en
P2860
P356
P1433
P1476
Molecular basis of cancer-ther ...... subclinical myocardial injury.
@en
P2093
Hardip Sandhu
Helen Maddock
P2860
P304
P356
10.1042/CS20120620
P407
P577
2014-03-01T00:00:00Z